| Remote ischaemic pre‐and delayed postconditioning–similar degree of cardioprotection but distinct mechanisms M Basalay, V Barsukevich, S Mastitskaya, A Mrochek, J Pernow, ... Experimental physiology 97 (8), 908-917, 2012 | 256 | 2012 |
| Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning MV Basalay, S Mastitskaya, A Mrochek, GL Ackland, AG Del Arroyo, ... Cardiovascular research 112 (3), 669-676, 2016 | 119 | 2016 |
| Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects MV Basalay, SM Davidson, AV Gourine, DM Yellon Basic research in cardiology 113, 1-15, 2018 | 87 | 2018 |
| The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection - evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and … SM Davidson, S Arjun, MV Basalay, RM Bell, DI Bromage, HE Bøtker, ... Basic Research in Cardiology 113, 43, 2018 | 79 | 2018 |
| Identifying the source of a humoral factor of remote (pre) conditioning cardioprotection S Mastitskaya, M Basalay, PS Hosford, AG Ramage, A Gourine, ... PLoS One 11 (2), e0150108, 2016 | 72 | 2016 |
| Intracellular sodium elevation reprograms cardiac metabolism D Aksentijević, A Karlstaedt, MV Basalay, BA O’Brien, D Sanchez-Tatay, ... Nature Communications 11 (1), 4337, 2020 | 57 | 2020 |
| Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against … S Nizari, MV Basalay, P Chapman, N Korte, A Korsak, IN Christie, ... Basic Research in Cardiology 116 (1), 32, 2021 | 49 | 2021 |
| Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide M Basalay, S Davidson, D Yellon Cardiovascular Drugs and Therapy 33 (227), 1-7, 2019 | 49 | 2019 |
| Distinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning V Barsukevich, M Basalay, J Sanchez, A Mrochek, J Whittle, GL Ackland, ... Basic Research in Cardiology 110, 1-11, 2015 | 45 | 2015 |
| Targeting myocardial ischaemic injury in the absence of reperfusion MV Basalay, DM Yellon, SM Davidson Basic Research in Cardiology 115 (6), 63, 2020 | 43 | 2020 |
| Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop RM Bell, M Basalay, HE Bøtker, S Beikoghli Kalkhoran, RD Carr, ... Basic Research in Cardiology 117 (1), 39, 2022 | 35 | 2022 |
| Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1) R Ang, S Mastitskaya, PS Hosford, M Basalay, M Specterman, Q Aziz, Y Li, ... Circulation Arrhythmia and Electrophysiology 11 (10), e006740, 2018 | 33 | 2018 |
| Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study MV Basalay, M Wiart, F Chauveau, C Dumot, C Leon, C Amaz, R Bolbos, ... Scientific Reports 10 (1), 16874, 2020 | 26 | 2020 |
| Reply: Glucagon-like peptide-1 mediates cardioprotection by remote ischaemic conditioning M Basalay, S Mastitskaya, A Mrochek, GL Ackland, AG Arroyo, J Sanchez, ... Cardiovascular research 113 (1), 13-14, 2017 | 10 | 2017 |
| Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality? MV Basalay, SM Davidson, DM Yellon Neural Regeneration Research 15 (10), 1852-1853, 2020 | 6 | 2020 |
| Right vs left vagus and cardioprotection conferred by remote ischaemic pre-and perconditioning M Basalay, V Barsukevich, A Mrochek, AV Gourine, A Gourine European Heart Journal 34 (suppl_1), 3697, 2013 | 4 | 2013 |
| The role of parasympathetic mechanisms in the infarct-limiting effect of SGLT2 inhibitor ertugliflozin MV Basalay, S Arjun, SM Davidson, DM Yellon Biorxiv, 2021.10. 01.462765, 2021 | 3 | 2021 |
| BS16 The role of parasympathetic nervous system in the infarct-limiting effect of SGLT2 inhibitors M Basalay, S Davidson, D Yellon Heart 107 (Suppl 1), A164-A164, 2021 | 1 | 2021 |
| P1 Causal link between intracellular sodium overload and metabolic remodelling in the heart: uncoupling ATP supply and demand? D Aksentijevic, A Karlstaedt, M Basalay, B O'Brien, A Thakker, D Tennant, ... Heart 104 (Suppl 3), A2-A3, 2018 | 1 | 2018 |
| Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomes. Basic Research in Cardiology, 2024 | | 2024 |